Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × capmatinib × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 9 OTHER 3 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

Capecitabine 8 Oxaliplatin 7 Drug Therapy 7 tislelizumab 6 pembrolizumab 6 Surgical Procedures, Operative 6 Docetaxel 6 Carboplatin 6 Bevacizumab 6 Saline Solution 5 Fluorouracil 5 Cisplatin 5 Standard of Care 4 Radiosurgery 4 Nivolumab 4 Laparoscopy 4 Gemcitabine 4 Exercise 4 Epirubicin 4 Cyclophosphamide 4 Control Groups 4 pertuzumab 3 Vincristine 3 Trastuzumab 3 Rituximab 3 Radiotherapy 3 Prednisone 3 Paclitaxel 3 Observation 3 Metformin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡